logo
Trump's Medicaid Cuts May Lead to Over 16,500 Deaths, New Study Predicts

Trump's Medicaid Cuts May Lead to Over 16,500 Deaths, New Study Predicts

Newsweek6 hours ago

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A new study by researchers at Harvard Medical School and City University of New York Hunter College predicts that the Republican-backed "big beautiful bill," now under debate in the Senate, could increase the number of annual deaths in the U.S. by more than 16,500 and leave 7.6 million more Americans without health insurance.
Why It Matters
President Donald Trump's massive U.S. budget proposal has drawn sharp criticism from some lawmakers and health experts over its proposed Medicaid cuts. The Congressional Budget Office (CBO) estimates the bill would slash the program by about $790 billion over the next decade to help offset roughly $4.5 trillion in tax breaks. Medicaid provides health coverage to tens of millions of low-income Americans, with around 71 million currently enrolled in the program.
The CBO estimates that more than 10 million Americans could lose their health coverage if the bill becomes law. Critics warn the move could lead to worse health outcomes nationwide and, over time, drive up medical costs. Supporters of the bill remain firm in their belief that the cuts are necessary to reduce the federal deficit.
Medicaid has expanded over time, most notably under former President Barack Obama through the Affordable Care Act, which broadened eligibility for low-income adults. While states contribute to Medicaid funding, the majority comes from the federal government—meaning proposed federal cuts would have a disproportionately large impact on the program.
Photo-illustration by Newsweek/Getty/Canva
What To Know
Researchers Dr. Adam Gaffney of Harvard Medical School and Dr. Steffie Woolhandler of City University of New York Hunter College published a study in the Annals of Internal Medicine, finding that the cuts would have profound nationwide impacts. The report estimated around 1.9 million people to lose access to a physician, 380,000 women to miss recommended mammograms and 7.6 million more uninsured Americans.
"When patients lose health coverage, they go without all types of care — visits to the doctor, prescription drugs, routine tests, and procedures. In fact, they may even avoid the emergency room when faced with serious issues, given fears of medical bills. Such delays can be deadly," Gaffney told Newsweek in an email statement.
Woolhandler, a primary care physician, told Newsweek in a phone call that visits to a health care provider are essential for early detection, as doctors can examine patients for mild conditions such as high blood pressure, blood sugar and cholesterol, "that we can treat to prevent complications." She added that doctors may also identify bumps, rashes or bowel changes that could be signs of serious conditions, including cancer or tumors.
"The simple reality is that modern medical care saves lives," Gaffney also said.
Health care like routine checkups, medication and access to preventive care such as mammograms are essential. Screening has nearly doubled early-stage breast cancer detection, according to a study published in The New England Journal of Medicine.
Drug prices are also likely to increase for Americans who get dropped from Medicaid, which may have deadly consequences.
The effects of the cuts will be nationwide, although there's potential that certain states may increase their contribution to keep more people in the program.
"It's a deep red state, but they have a very large share of their population on Medicaid, and Louisiana is going to be very, very hard hit," Woolhandler said, adding, "the recipients themselves are going to lose their Medicaid, the hospitals and clinics there are going to lose a huge part of their funding."
Rural hospitals often rely on Medicaid, with the American Hospital Association's analysis suggesting that the Republicans' "big beautiful bill" would result in a $50 billion reduction in federal Medicaid spending on those medical centers over 10 years.
" If you take away people's medical care, their health suffers and they die younger," Woolhandler said.
What People Are Saying
John Connolly, Medicaid director and deputy commissioner at the Minnesota Department of Human Services, said in a media briefing last week, as shared with Newsweek by the agency: "[The bill] achieves its purported reductions by slashing federal Medicaid funding. But those reductions are actually a cost shift - to states, counties, Tribes, providers and people themselves who will have to pick up the expense of health care no longer covered and the cost of increased administrative burdens."
Republican Representative Tony Gonzales said last month: "After four years of disastrous national security and economic policies, we're putting America back on the right track. This morning, I voted yes on the House reconciliation package, which includes funding to reimburse our state for Operation Lone Star costs, a priority I've fought for since House budget talks began."
What Happens Next
The "big beautiful bill" is under debate in the Senate. If passed, it advances to Trump, who has said he would sign the bill into law.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Renewable energy firm EDPR sticking to US plans despite tax credit cuts
Renewable energy firm EDPR sticking to US plans despite tax credit cuts

Yahoo

time12 minutes ago

  • Yahoo

Renewable energy firm EDPR sticking to US plans despite tax credit cuts

By Sergio Goncalves LISBON (Reuters) -EDP ​​Renovaveis, the world's fourth-largest wind energy producer, will stick to its goal of installing up to 1.75 gigawatts of new capacity in the U.S. by the end of 2026 even if tax credits for renewables are phased out, its CEO said. The Republican-controlled U.S. House of Representatives approved a budget reconciliation bill last month, which weakens clean-energy tax credits included in the 2022 Inflation Reduction Act. Though the Senate could still amend the bill, in its current form it would abruptly terminate several credits 60 days after its enactment for projects that have not yet begun construction, making most of them unfeasible. "For 2025 and 2026, I think we will maintain our forecasts in terms of results and installation of new capacity," the Portuguese firm's CEO Miguel Stilwell d'Andrade told reporters on the sidelines of a conference late on Monday. EDPR is currently preparing a new business plan to be disclosed on November 6 that will go beyond 2027. "The renewables bet in the U.S. is here to stay. In 2024, we installed 2 GW there and this year we will install 1 GW and up to 750 megawatts in 2026 as planned," he said. The exact level of investment from 2027 onwards would depend on what is approved in the final version of the reconciliation bill, he added. "Let's see what comes out of the Senate," he said. Senator John Curtis, one of a handful of Senate Republicans who have said they want to preserve some of the tax credits, said last week that changes to the bill were necessary to protect investors and jobs from major disruption. EDPR, which operates in 28 countries across Europe, Asia and the Americas, had installed capacity of 19.3 GW in December 2024, 51% of which was in the United States. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Oil climbs after Trump's Tehran warning, Sasol now up 80% since April
Oil climbs after Trump's Tehran warning, Sasol now up 80% since April

News24

time13 minutes ago

  • News24

Oil climbs after Trump's Tehran warning, Sasol now up 80% since April

• For more financial news, go to the News24 Business front page. Oil prices jumped on Tuesday after US president Donald Trump call for Tehran residents to evacuate. Brent crude rose more than 1% to $74.15 a barrel. A month ago, it was trading close to $60. The synthetic fuels group Sasol's share price continued its surge from Friday. By late morning on Tuesday, it was trading at R99.43. It was trading at R87 on Thursday, before Israel's attacks on its regional foes. Its shares have now gained 80% since it reached its lowest level since the pandemic in April. Sasol has been grappling with the fallout of a disastrous US chemicals project, which resulted in a huge debt burden. After Friday's surge sparked by the attacks, crude ticked more than one percent lower Monday as traders bet that the conflict would not spread throughout the Middle East and key oil sites were mostly left untouched. Prices bounced back Tuesday after Trump called for the evacuation of the Iranian capital, which is home to nearly 10 million people. "Iran should have signed the 'deal' I told them to sign," he said on social media, referring to nuclear talks that were taking place. "What a shame, and waste of human life. Simply stated, IRAN CAN NOT HAVE A NUCLEAR WEAPON. I said it over and over again! Everyone should immediately evacuate Tehran!" Trump later poured cold water on remarks from French President Emmanuel Macron that he was leaving the G7 summit in Canada to discuss a possible ceasefire. Gains were tempered after the International Energy Agency said in its 2025 report that global demand would fall slightly in 2030 for the first time since the start of the Covid pandemic in 2020. It cited "below-trend economic growth, weighed down by global trade tensions and fiscal imbalances, and the accelerating substitution away from oil in the transport and power generation sectors". Traders are keeping a wary eye on developments in the Iran crisis, with the aircraft carrier USS Nimitz leaving Southeast Asia on Monday after cancelling a Vietnam visit as the Pentagon announced it was sending "additional capabilities" to the Middle East. Trump has maintained that Washington has "nothing to do" with Israel's campaign, but Iran's foreign minister said Monday the US leader could halt the attacks with "one phone call". Tehran has said it would hit US sites if Washington got involved. Meanwhile, Britain, France and Germany called on Iran to quickly return to the negotiating table over its nuclear programme, a French diplomatic source said. The US president had earlier said Iran wanted to make a deal, adding "as soon as I leave here, we're going to be doing something". He later left the gathering in the Rockies, telling reporters: "I have to be back as soon as I can. I wish I could stay for tomorrow, but they understand, this is big stuff." Tehran had signalled a desire to de-escalate and resume nuclear talks with Washington as long as the United States did not join the conflict, according to the Wall Street Journal. Rand recovers After briefly breaking through R18/$ on Friday, the rand strengthened to R17.8177 by mid-morning on Tuesday. The rand has lost half a percent of its value against the dollar over the past week. Equities were mixed in Asian trade, with Tokyo, Singapore, Seoul, Manila, Bangkok, Jakarta and Taipei all advancing, while Hong Kong, Sydney, Wellington and Mumbai struggled along with London, Paris and Frankfurt. The JSE's All-Share index was 0.3% lower, with Harmony (-3.9%), AngloGold (-3.4%) and Gold Fields (-3%) among the biggest losers. Dealers also kept tabs on the G7 summit, where world leaders pushed back against Trump's trade war, arguing it posed a risk to global economic stability. Britain, Canada, Italy, Japan, Germany and France called on the president to reverse course on his plans to impose even steeper tariffs on countries across the globe next month.

The trickle-down effect of President Trump's massive NIH budget cuts
The trickle-down effect of President Trump's massive NIH budget cuts

USA Today

time20 minutes ago

  • USA Today

The trickle-down effect of President Trump's massive NIH budget cuts

The trickle-down effect of President Trump's massive NIH budget cuts U.S. medical research is at a precipice as President Trump proposes cutting $18 billion from the National Institutes of Health. Show Caption Hide Caption Cuts to health research could impact clinical studies and trials at the NIH The Trump administration wants to cut health spending in the coming year, and plans to cut the budget at the National Institutes of Health by $18 billion. Trump administration officials say they are restoring trust in public health and cutting waste. Universities said the Trump administration is marking important studies as Diversity, Equity and Inclusion programs and mistakenly cutting their funding. Fyodor Urnov left the Soviet Union for the United States more than 35 years ago with a dream: To become a scientist and cure rare diseases in the country that was a beacon for biomedical research. Umrov recently was a key member of a team that used gene editing technology to treat a 'stinking cute' New Jersey baby born with a severe disability. That breakthrough, like decades of other medical research he's done, was funded by the National Institutes of Health. But millions of dollars in NIH research has now ground to a halt at universities across the country after the Trump administration cut studies it says are driven by diversity initiatives or a fixation on COVID-19. And the remaining research stands at a precipice as President Donald Trump's budget proposes cutting $18 billion from the NIH next year – the largest cut to any single government agency. NIH grant money doesn't sit in Washington – it gets funneled down to research universities across the country, where professors, graduate students, and doctors do their life's work. The schools include prestigious Ivy League institutions, such as Harvard University, and dozens of lesser-known private and public colleges. 'I really hope that we're going through a focused, phased of review of how funding is distributed,' Urnov said. 'I just cannot imagine a future where American biomedical research is not the shining light that leads the world.' On Jan. 16, a federal judge in Boston said NIH's cancellation of more than $1 billion in research grants on the basis of DEI was illegal and reinstated them. He signaled he could issue a more sweeping decision in the case as it moves forward. But Trump officials say they are restoring trust in public health and cutting waste. 'In recent years, Americans have lost confidence in our increasingly politicized healthcare and research apparatus that has been obsessed with DEI and COVID, which the majority of Americans moved on from years ago,' Kush Desai, a spokesman for the White House, said in a statement. 'The Trump administration is focused on restoring the Gold Standard of Science – not ideological activism … to finally address our chronic disease epidemic.' Texas university loses virus catalog funding The University of Texas Medical Branch in Galveston, which receives about $150 million in NIH grants annually, has already lost $19.3 million, according to Scott Weave, the scientific director for Galveston National Laboratory. Weaver said he's most concerned about the World Reference Center, a collection of thousands of viruses that has been preserved since the 1950s to help scientists conduct emergency research into new viral threats, such as Zika or West Nile virus. In recent years, the research focused on COVID-19. NIH terminated the center's grant funding in full on March 24. In a letter obtained by USA TODAY, the agency wrote: 'These grant funds were issued for a limited purpose: to ameliorate the effects of the pandemic. Now that the pandemic is over, the grant funds are no longer necessary.' Weaver said that framing is incorrect. The project on viruses isn't just focused on COVID-19. Historically, the center worked on mosquito-borne viruses, not respiratory ones. The group only pivoted briefly to help with the pandemic health emergency. He believes the grant was eliminated in error. 'I think it would've been clear if anyone with an understanding of science had read the information about of our grant that we were not a COVID grant,' Weaver said. Research programs mistaken for DEI Andy Johns, who administers research grants at the University of North Carolina at Chapel Hill, described a similar situation. The school lost $7.7 million in NIH contract terminations, which he said began in February but picked up pace in March and April. The cuts include a study on how to improve tobacco regulatory science to reduce health disparities, a study to address COVID-19 vaccine hesitancy in rural communities, a study on neurobiological susceptibility to peer pressure and drug use among teenagers, and a study on malaria in Africa. 'The ones that might sting the most are ones that get caught up because they're perceived as being involving a particular issue that they don't actually involve – where a project may have been deemed as DEI, but there's actually not a DEI focus in any way shape or form,' Johns said. Sometimes, only a small portion of a research project involves analyzing how research affects a specific demographic, experts said, but this has been enough for the Trump administration to flag the grant as DEI. Johns said professors involved in the defunded studies asked NIH to let them continue the underlying scientific research and simply omit the demographic analysis. But the university hasn't haven't seen much success with this approach, he said. Weaver, the Texas researcher, mentioned a grant that helped students who graduated from small colleges that lack research opportunities get research experience before applying to PhD programs. He said NIH cut that on the grounds it was a DEI initiative. Weaver said that while the grant may have technically fit into that category, it was 'more opportunity-based.' He lamented what stripping the campus of the program means: 'I've really taken a lot of pleasure in seeing them succeed and go on and thrive as scientists.' Layoffs in Maryland and California Daniel Mullins, a health outcomes professor at the University of Maryland, Baltimore, said he laid off off five people and reduced the workload of a sixth worker after NIH told them to stop work on a five-year, $9.4 million grant for a health care study. The grant helped Mullins study how to make patients more likely to participate in clinical trials − a vital step in the approval of new medicines. He describes the program as a 'health equity hub,' but says there's no one disease or demographic of people it is specifically designed to help. Mullins' biggest challenge has been walking into work every day and seeing people who are about to lose their jobs. 'I asked the department chair and the dean if we could just fund these people a little bit so they could at least find a job,' he said. Kim Elaine Barrett, the vice dean of research at the University of California Davis School of Medicine, said her school lost grants aimed at building a biomedical workforce that is more representative of the population. Other terminated grants provided stipends and salaries for graduate students and junior faculty. Barrett said the school historically received just over $200 million a year from the National Institutes of Health. She said the funding loss affects about 100 people. "If the situation continues for much longer, and/or gets worse, then we will have to start looking at layoffs, and not just for trainees, but for lab personnel in general," Barrett said. "A lot of faculty derive some or all of their salaries from research grants." 'I wish we had better medications' At Northwestern University, just outside of Chicago, Dr. Benjamin Singer, the vice chair for research in the Department of Medicine, said the university has been 'very gracious' in helping his research group fill in the funding gaps to keep his research group's work going. Singer treats patients in the intensive care unit, and some of his research focuses on how a specific cell can help rebuild a damaged lung – research that can benefit people suffering from pneumonia. His group also identifies targets for potential future prescription drugs. 'I take care of critically ill patients at a high risk of dying,' Singer said. 'When they're really up against a tough spot, I think, 'I wish we had better medications. I wish we had better therapies to help your mom, your son, your daughter.'' The University of Minnesota, which reported losing 24 NIH grants as of early May, created a program to help researchers continue their work if their funding was terminated or they received a stop-work order from the federal government. 'I just can't be clear enough, however," said Rebecca Cunningham, the university's president. "There is no mitigation for the loss of federal funding.' Contributing: Reuters

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store